Skip to content
Recall Observatory FDA recall evidence

Drug product

Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37

D-0185-2024

January 26, 2022

Class II

Product summary

Firm
CARDINAL HEALTHCARE
Event
Event 89450
Status
Terminated
Classification
Class II
Quantity
1 unit
Official record key
drug-enforcement:D-0185-2024

Official wording

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Code information: Batch D41919

Distribution pattern: Nationwide USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations